Viewing Study NCT00198133

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:02 AM
Ignite Modification Date: 2025-12-30 @ 10:24 PM
Study NCT ID: NCT00198133
Status: COMPLETED
Last Update Posted: 2019-07-22
First Post: 2005-09-12
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma
Sponsor: Patrick Joseph Loehrer Sr.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Thymoma View
None Thymic Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Thymoma View
None Thymic Carcinoma View